Genetic variations in miRNAs binding site might participate in cancer risk. This study aimed to systematically review the association between miRNA-binding site polymorphisms and colorectal cancer (CRC). Electronic literature search was carried out on PubMed, Web of Science (WOS), Scopus, and Embase. All types of observational studies till 30 November 2018 were included. Overall 85 studies (21 SNPs) from two systematic searches were included analysis. The results showed that in the Middle East population, the minor allele of rs731236 was associated with decreased risk of CRC (heterozygote model: 0.76 [0.61-0.95]). The minor allele of rs3025039 was related to increased risk of CRC in East Asian population (allelic model: 1.25 [1.01-1.54]). Results for rs3212986 were significant in overall and subgroup analysis (P < .05). For rs1801157 in subgroup analysis the association was significant in Asian populations (including allelic model: 2.28 [1.11-4.69]). For rs712, subgroup analysis revealed a significant (allelic model: 1.41 [1.23-1.61]) and borderline (allelic model: 0.92 [0.84-1.00]) association in Chinese and Czech populations, respectively. The minor allele of rs17281995 increased risk of CRC in different genetic models (P < .05). Finally, rs5275, rs4648298, and rs61764370 did not show significant associations. In conclusion, minor allele of rs3025039, rs3212986, and rs712 polymorphisms increases the risk of CRC in the East Asian population, and heterozygote model of rs731236 polymorphism shows protective effect in the Middle East population. In Europeans, the minor allele of rs17281995 may increase the risk of CRC, while rs712 may have a protective effect. Further analysis based on population stratifications should be considered in future studies.

Department of Gastroenterology Imam Khomeini Hospital Tehran University of Medical Sciences Tehran Iran

Department of Medical Genetics Faculty of Medicine Tabriz University of Medical Sciences Tabriz Iran

Elderly Health Research Center Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran

Endocrinology and Metabolism Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran

Evidence Based Practice Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran

Metabolic Disorders Research Center Endocrinology and Metabolism Molecular Cellular Sciences Institute Tehran University of Medical Sciences Tehran Iran

Obesity and Eating Habits Research Center Endocrinology and Metabolism Clinical Sciences Institute Tehran University of Medical Sciences Tehran Iran

Zobrazit více v PubMed

Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87‐108. PubMed

American Cancer Society . Global Cancer Facts & Figures, 3rd edn Atlanta: American Cancer Society; 2015.

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D. F B. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. PubMed

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394‐424. PubMed

Bray F, Møller B. Predicting the future burden of cancer. Nat Rev Cancer. 2006;6:63. PubMed

Nowatzki J, Moller B, Demers A. Projection of future cancer incidence and new cancer cases in Manitoba, 2006–2025. Chronic Dis Injuries Can. 2011;31:71‐78. PubMed

Mahan LK, Raymond JL. Krause's Food & the Nutrition Care Process‐E‐Booked. Winnipeg, Canada: Elsevier Health Sciences; 2016.

Incisive Health . Saving Lives, Averting Costs: An Analysis of the Financial Implications of Achieving Earlier Diagnosis of Colorectal, Lung and Ovarian Cancer. London: Incisive Health/Cancer Research UK; 2014.

Ferlay J, Parkin D, Steliarova‐Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46:765‐781. PubMed

Azzoni C, Bottarelli L, Campanini N, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis. 2007;22:115‐126. PubMed

Bognar G, Ledniczky G, Istvan G, Ondrejka P. Molecular mechanisms in development of colorectal cancer metastasis. Magyar Sebeszet. 2006;59:342‐349. PubMed

Friedman RC, Farh KK‐H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92‐105. PubMed PMC

Liu F, Dear K, Huang L, et al. Association between microRNA‐27a rs895819 polymorphism and risk of colorectal cancer: a meta‐analysis. Cancer Genetics. 2016;209:388‐394. PubMed

Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389. PubMed PMC

Gong J, Tong Y, Zhang HM, et al. Genome‐wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis. Hum Mutat. 2012;33:254‐263. PubMed

Wu M, Jolicoeur N, Li Z, et al. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis. 2008;29:1710‐1716. PubMed

Xu L, Tang W. Associations of polymorphisms in mir‐196a2, mir‐146a and mir‐149 with colorectal cancer risk: a meta‐analysis. Pathol Oncol Res. 2016;22:261‐267. PubMed

Liu X‐X, Wang M, Xu D, et al. Quantitative assessment of the association between genetic variants in microRNAs and colorectal cancer risk. Biomed Res Int. 2015;2015:1–10. PubMed PMC

Rong G‐Q, Zhang X‐M, Chen B, Yang X‐D, Wu H‐R, Gong W. MicroRNA gene polymorphisms and the risk of colorectal cancer. Oncol Lett. 2017;13:3617‐3623. PubMed PMC

Kim JG, Chae YS, Lee SJ, et al. Genetic variation in microRNA‐binding site and prognosis of patients with colorectal cancer. J Cancer Res Clin Oncol. 2015;141:35‐41. PubMed

Esquela‐Kerscher A, Slack FJ. Oncomirs–microRNAs with a role in cancer. Nat Rev Cancer. 2006;6:259. PubMed

Landi D, Gemignani F, Naccarati A, et al. Polymorphisms within micro‐RNA‐binding sites and risk of sporadic colorectal cancer. Carcinogenesis. 2008;29:579‐584. PubMed

Chen K, Rajewsky N. Natural selection on human microRNA binding sites inferred from SNP data. Nat Genet. 2006;38:1452. PubMed

Vaishnavi V, Manikandan M, Munirajan AK. Mining the 3′ UTR of autism‐implicated genes for SNPs perturbing microRNA regulation. Genomics, Proteomics Bioinformatics. 2014;12:92‐104. PubMed PMC

Gopalakrishnan C, Kamaraj B, Purohit R. Mutations in microRNA binding sites of CEP genes involved in cancer. Cell Biochem Biophys. 2014;70:1933‐1942. PubMed

Langevin SM, Christensen BC. Let‐7 microRNA‐binding‐site polymorphism in the 3′ UTR of KRAS and colorectal cancer outcome: a systematic review and meta‐analysis. Cancer Med. 2014;3:1385‐1395. PubMed PMC

Li J, Li Z, Kan Q, Sun S, Li Y, Wang S. Association of p21 3′ UTR gene polymorphism with cancer risk: evidence from a meta‐analysis. Sci Rep. 2015;5:13189. PubMed PMC

Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta‐analysis protocols (PRISMA‐P) 2015 statement. Systematic Rev. 2015;4:1. PubMed PMC

Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta‐analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097. PubMed PMC

Gholami M, Amoli MM, Sharifi F. Letter to the Editor: Comments on “Association between the ICAM‐1 gene polymorphism and coronary heart disease risk: a meta‐analysis”. Biosci Rep. 2019;39:BSR20190554. PubMed PMC

Xiong F, Wu C, Chang J, et al. Genetic variation in an miRNA‐1827 binding site in MYCL1 alters susceptibility to small‐cell lung cancer. Cancer Res. 2011;71:5175‐5181. PubMed

Zhang L, Liu Y, Song F, et al. Functional SNP in the microRNA‐367 binding site in the 3′ UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc Natl Acad Sci. 2011;108:13653‐13658. PubMed PMC

Salzman DW, Weidhaas JB. SNPing cancer in the bud: microRNA and microRNA‐target site polymorphisms as diagnostic and prognostic biomarkers in cancer. Pharmacol Ther. 2013;137:55‐63. PubMed PMC

Kang BW, Jeon H‐S, Chae YS, et al. Impact of genetic variation in MicroRNA‐binding site on susceptibility to colorectal cancer. Anticancer Res. 2016;36:3353‐3361. PubMed

Saridaki Z, Weidhaas JB, Lenz H‐J, et al. A let‐7 microRNA‐binding site polymorphism in KRAS predicts improved outcome in patients with metastatic colorectal cancer treated with salvage cetuximab/panitumumab monotherapy. Clin Cancer Res. 2014;20:4499‐4510. PubMed PMC

Jiang Q‐H, Peng H‐X, Zhang Y, Tian P, Xi Z‐L, Chen H. rs712 Polymorphism within let‐7 microRNA‐binding site might be involved in the initiation and progression of colorectal cancer in Chinese population. OncoTargets Ther. 2015;8:3041. PubMed PMC

Zanetti KA, Haznadar M, Welsh JA, et al. 3′‐UTR and functional secretor haplotypes in mannose‐binding lectin 2 are associated with increased colon cancer risk in African Americans. Cancer Res. 2012;72:1467‐1477. PubMed PMC

He H, Lei L, Chen E, et al. The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes. Cancer Biol Ther. 2017;18:407‐413. PubMed PMC

Mao Y‐Y, Jing F‐Y, Jin M‐J, et al. rs12904 polymorphism in the 3UTR of EFNA1 is associated with colorectal cancer susceptibility in a Chinese population. Asian Pac J Cancer Prev. 2013;14:5037‐5041. PubMed

Li J, Liu H, Zou LI, et al. A functional variant in GREM1 confers risk for colorectal cancer by disrupting a hsa‐miR‐185‐3p binding site. Oncotarget. 2017;8:61318. PubMed PMC

Ding L, Jiang Z, Chen Q, Qin R, Fang Y, Li H. A functional variant at miR‐520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population. Biomed Res Int. 2015;2015:1–5. PubMed PMC

Mosallayi M, Simonian M, Khosravi S, et al. Polymorphism (rs16917496) at the miR‐502 binding site of the lysine methyltransferase 5A (SET8) and its correlation with colorectal cancer in Iranians. Adv Biomed Res. 2017;6:77. PubMed PMC

Garziera M, Catamo E, Crovella S, et al. Association of the HLA‐G 3′ UTR polymorphisms with colorectal cancer in Italy: a first insight. Int J Immunogenet. 2016;43:32‐39. PubMed

Yang Y, Ding J, Gao Z‐G, Wang Z‐J. A variant in SIRT2 gene 3′‐UTR is associated with susceptibility to colorectal cancer. Oncotarget. 2017;8:41021. PubMed PMC

Chen J, Shi YI, Li Z, et al. A functional variant of IC53 correlates with the late onset of colorectal cancer. Mol Med. 2011;17:607‐618. PubMed PMC

Ahangari F, Salehi R, Salehi M, Khanahmad H. A miRNA‐binding site single nucleotide polymorphism in the 3′‐UTR region of the NOD2 gene is associated with colorectal cancer. Med Oncol. 2014;31:173. PubMed

Chang J, Tian J, Yang Y, et al. A rare missense variant in TCF7L2 associates with colorectal cancer risk by interacting with a GWAS‐identified regulatory variant in the MYC enhancer. Cancer Res. 2018;78:5164‐5172. PubMed

Datta S, Sherva RM, De La Cruz M, et al. Single nucleotide polymorphism facilitated down‐regulation of the cohesin stromal antigen‐1: implications for colorectal cancer racial disparities. Neoplasia. 2018;20:289‐294. PubMed PMC

Mosallaei M, Simonian M, Ahangari F, et al. Single nucleotide polymorphism rs4648298 in miRNAs hsa‐miR21 and hsa‐miR590 binding site of COX gene is a strong colorectal cancer determinant. J Gastrointestinal Oncol. 2018;9:448. PubMed PMC

Ni H, Su B, Pan L, Li X, Zhu X, Chen X. Functional variants inPXRare associated with colorectal cancer susceptibility in Chinese populations. Cancer Epidemiol. 2015;39:972‐977. PubMed

Gansmo LB, Romundstad P, Birkeland E, et al. MDM4 SNP34091 (rs4245739) and its effect on breast‐, colon‐, lung‐, and prostate cancer risk. Cancer Med. 2015;4:1901‐1907. PubMed PMC

Lu S, Bevier M, Huhn S, et al. Genetic variants in C‐type lectin genes are associated with colorectal cancer susceptibility and clinical outcome. Int J Cancer. 2013;133:2325‐2333. PubMed

Shaker OG, Mohammed SR, Mohammed AM, Mahmoud Z. Impact of micro RNA‐375 and its target gene SMAD‐7 polymorphism on susceptibility of colorectal cancer. J Clin Lab Anal. 2018;32:e22215. PubMed PMC

Ross J, Lockett L, Brookes D, et al. An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non‐syndromic predisposition. Eur J Hum Genet. 2013;21:1389. PubMed PMC

Nejat D, Zubeyde Y, Orkun G. The K‐ras let‐7 miRNA binding site variant and K‐ras mutations in colon cancer. [abstract]. In: Proceedings of the AACR Special Conference on RAS Oncogenes: From Biology to Therapy; Feb 24–27, 2014; Lake Buena Vista, FL. Philadelphia (PA): AACR. Mol Cancer Res 2014;12(12 Suppl): Abstract nr A48.

Kjersem JB, Ikdahl T, Guren T, et al. Let‐7 miRNA‐binding site polymorphism in the KRAS 3′ UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5‐fluorouracil and oxaliplatin+/− cetuximab. BMC Cancer. 2012;12:534. PubMed PMC

Simonian M, Mosallayi M, Miraghajani M, et al. Single nucleotide polymorphism rs696 in miR449a binding site of NFKBIA gene is correlated with risk of colorectal cancer. Gastroenterol Hepatol Bed Bench. 2018;11:48. PubMed PMC

Song S, Chen D, Lu J, et al. NFκB1 and NFκBIA polymorphisms are associated with increased risk for sporadic colorectal cancer in a southern Chinese population. PLoS ONE. 2011;6:e21726. PubMed PMC

Pan X‐M, Sun R‐F, Li Z‐H, et al. A let‐7 KRAS rs712 polymorphism increases colorectal cancer risk. Tumor Biol. 2014;35:831‐835. PubMed

Alhadheq AM, Purusottapatnam Shaik J, Alamri A, et al. The effect of poly (ADP‐Ribose) polymerase‐1 gene 3′ untranslated region polymorphism in colorectal cancer risk among Saudi cohort. Dis Markers. 2016;2016. PubMed PMC

Gong J, Shen N, Zhang H‐M, et al. A genetic variant in microRNA target site of TGF‐β signaling pathway increases the risk of colorectal cancer in a Chinese population. Tumor Biol. 2014;35:4301‐4306. PubMed

Dai Q, Wei HL, Huang J, Zhou TJ, Chai L, Yang Z‐H. KRAS polymorphisms are associated with survival of CRC in Chinese population. Tumor Biol. 2016;37:4727‐4734. PubMed

Ye P, Li Z, Jiang H, Liu T. SNPs in microRNA‐binding sites in the ITGB1 and ITGB3 3′‐UTR increase colorectal cancer risk. Cell Biochem Biophys. 2014;70:601‐607. PubMed

Chaleshi V, Tajali R, Savabkar S, et al. Lack of association between NOD2 rs3135500 and IL12B rs1368439 microRNA binding site SNPs and colorectal cancer susceptibility in an Iranian population. Microrna. 2016;5:152‐156. PubMed

Wu X‐M, Yang H‐G, Zheng B‐A, Cao H‐F, Hu Z‐M, Wu W‐D. Functional genetic variations at the microRNA binding‐site in the CD44 gene are associated with risk of colorectal cancer in Chinese populations. PLoS ONE. 2015;10:e0127557. PubMed PMC

Slaby O, Sachlova M, Brezkova V, et al. Identification of microRNAs regulated by isothiocyanates and association of polymorphisms inside their target sites with risk of sporadic colorectal cancer. Nutr Cancer. 2013;65:247‐254. PubMed

Yu Y, Zhou J, Gong C, et al. Dietary factors and microRNA‐binding site polymorphisms in the IL13 gene: risk and prognosis analysis of colorectal cancer. Oncotarget. 2017;8:47379. PubMed PMC

Lee A‐R, Park J, Jung KJ, Jee SH, Kim‐Yoon S. Genetic variation rs7930 in the miR‐4273‐5p target site is associated with a risk of colorectal cancer. OncoTargets Ther. 2016;9:6885. PubMed PMC

Gu D, Li S, Du M, et al. A genetic variant located in the miR‐532‐5p‐binding site of TGFBR1 is associated with the colorectal cancer risk. J Gastroenterol. 2019;54:141‐148. PubMed

Catalano C, da Silva Filho MI, Frank C, et al. Investigation of single and synergic effects of NLRC5 and PD‐L1 variants on the risk of colorectal cancer. PLoS ONE. 2018;13:e0192385. PubMed PMC

Ke J, Tian J, Li J, et al. Identification of a functional polymorphism affecting microRNA binding in the susceptibility locus 1q25. 3 for colorectal cancer. Mol Carcinog. 2017;56:2014‐2021. PubMed

Zhang Q, Zheng X, Li X, et al. The polymorphisms of mi RNA‐binding site in MLH 3 and ERCC 1 were linked to the risk of colorectal cancer in a case–control study. Cancer Med. 2018;7:1264‐1274. PubMed PMC

Zhao Y, Yang H, Luo X, Wang C, Zhang R, Guo Z. Single nucleotide polymorphisms at the microRNA‐binding site of KIAA0423 are associated with colorectal cancer. Biotechnol Biotechnol Equip. 2016;30:1163‐1167.

Azimzadeh P, Romani S, Mohebbi SR, et al. Association of polymorphisms in microRNA‐binding sites and colorectal cancer in an Iranian population. Cancer Genet. 2012;205:501‐507. PubMed

Naccarati A, Pardini B, Stefano L, et al. Polymorphisms in miRNA‐binding sites of nucleotide excision repair genes and colorectal cancer risk. Carcinogenesis. 2012;33:1346‐1351. PubMed

Schneiderova M, Naccarati A, Pardini B, et al. MicroRNA‐binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis. Mutagenesis. 2017;32:533‐542. PubMed

Gong J, Tian J, Lou J, et al. A functional polymorphism in lnc‐LAMC2‐1: 1 confers risk of colorectal cancer by affecting miRNA binding. Carcinogenesis. 2016;37:443‐451. PubMed

Vymetalkova V, Pardini B, Rosa F, et al. Polymorphisms in microRNA binding sites of mucin genes as predictors of clinical outcome in colorectal cancer patients. Carcinogenesis. 2017;38:28‐39. PubMed

Landi D, Gemignani F, Pardini B, et al. Identification of candidate genes carrying polymorphisms associated with the risk of colorectal cancer by analyzing the colorectal mutome and microRNAome. Cancer. 2012;118:4670‐4680. PubMed

Pardini B, Rosa F, Barone E, et al. Variation within 3′‐UTRs of base excision repair genes and response to therapy in colorectal cancer patients: a potential modulation of microRNAs binding. Clin Cancer Res. 2013;19:6044‐6056. PubMed

Naccarati A, Rosa F, Vymetalkova V, et al. Double‐strand break repair and colorectal cancer: gene variants within 3′ UTRs and microRNAs binding as modulators of cancer risk and clinical outcome. Oncotarget. 2016;7:23156. PubMed PMC

Naumov I, Lisiansky V, Kazanov D, et al. Polymorphisms in the CD24 gene play a role in the risk for colorectal neoplasia. Gastroenterology. 2011;140:S‐98.

Liu B, Zhang Y, Jin M, et al. Association of selected polymorphisms of CCND1, p21, and caspase8 with colorectal cancer risk. Mol Carcinog. 2010;49:75‐84. PubMed

Laczmanska I, Laczmanski L, Bebenek M, et al. Vitamin D receptor gene polymorphisms in relation to the risk of colorectal cancer in the Polish population. Tumor Biol. 2014;35:12397‐12401. PubMed PMC

Vymetalkova V, Pardini B, Rosa F, et al. Variations in mismatch repair genes and colorectal cancer risk and clinical outcome. Mutagenesis. 2014;29:259‐265. PubMed

Timofeeva MN, Kinnersley B, Farrington SM, et al. Recurrent coding sequence variation explains only a small fraction of the genetic architecture of colorectal cancer. Sci Rep. 2015;5:16286. PubMed PMC

Pazienza P, Actis G, Borghesio E, et al. CD86 genetic variants are associated with colorectal cancer (CRC) and ulcerative colitis, but not adenoma, risk: a clue to a different pathogenetic mechanism of CRC? Digestive Liver Dis. 2011;43:S196.

Dimberg J, Hugander A, Löfgren S, Wågsäter D. Polymorphism and circulating levels of the chemokine CXCL12 in colorectal cancer patients. Int J Mol Med. 2007;19:11‐15. PubMed

Hidalgo‐Pascual M, Galan J, Chaves‐Conde M, et al. Analysis of CXCL12 3'UTR G> A polymorphism in colorectal cancer. Oncol Rep. 2007;18:1583‐1587. PubMed

Shi M‐D, Chen J‐H, Sung H‐T, Lee J‐S, Tsai L‐Y, Lin H‐H. CXCL12‐G801A polymorphism modulates risk of colorectal cancer in Taiwan. Arch Med Sci. 2013;9:999. PubMed PMC

Bellido F, Guinó E, Jagmohan‐Changur S, et al. Genetic variant in the telomerase gene modifies cancer risk in Lynch syndrome. Eur J Hum Genet. 2013;21:511. PubMed PMC

Kang M‐J, Jung S‐A, Jung JM, et al. Associations between single nucleotide polymorphisms of MMP2, VEGF, and HIF1A genes and the risk of developing colorectal cancer. Anticancer Res. 2011;31:575‐584. PubMed

Savabkar S, Chaleshi V, Farahbakhsh FB, et al. VEGF gene+ 936C/T polymorphism decreases the risk of colorectal cancer. Eur J Oncol. 2015;20:88‐93.

Bae SJ, Kim JW, Kang H, Hwang SG, Oh D, Kim NK. Gender‐specific association between polymorphism of vascular endothelial growth factor (VEGF 936 C> T) gene and colon cancer in Korea. Anticancer Res. 2008;28:1271‐1276. PubMed

Ungerbäck J, Elander N, Dimberg J, Söderkvist P. Analysis of VEGF polymorphisms, tumor expression of VEGF mRNA and colorectal cancer susceptibility in a Swedish population. Mol Med Rep. 2009;2:435‐439. PubMed

Joshi AD, Corral R, Siegmund KD, et al. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis. 2008;30:472‐479. PubMed PMC

Zhao Y, Du Y, Zhao S, Guo Z. Single‐nucleotide polymorphisms of microRNA processing machinery genes and risk of colorectal cancer. OncoTargets Ther. 2015;8:421. PubMed PMC

Andersen V, Østergaard M, Christensen J, Overvad K, Tjønneland A, Vogel U. Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case‐cohort study. BMC Cancer. 2009;9:407. PubMed PMC

Stacey SN, Sulem P, Jonasdottir A, et al. A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet. 2011;43:1098. PubMed PMC

Pereira C, Pimentel‐Nunes P, Brandao C, Moreira‐Dias L, Medeiros R, Dinis‐Ribeiro M. COX‐2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention. Eur J Gastro Hepatol. 2010;22:607‐613. PubMed

Ying Z, Chang‐Ming L, Jian‐Zhi Z, Xiao‐Qin C. Relationship between polymorphisms in the promoter region of the COX‐2 gene and susceptibility to colorectal cancer. World Chinese J Digestol. 2012;20:1579‐1584.

Mohd Shafi'i MS, Shahpudin S, Mustapha MA, et al. The genetic variation A> G at 3'UTR of nuclear factor kappa B 1 A (NFkB1A) influences susceptibility of sporadic colorectal cancer in Malaysian population. Int Med J. 2012;19:98‐101.

Mullany LE, Wolff RK, Herrick JS, Buas MF, Slattery ML. SNP regulation of microRNA expression and subsequent colon cancer risk. PLoS ONE. 2015;10:e0143894. PubMed PMC

Gao J, Pfeifer D, He L‐J, et al. Association of NFKBIA polymorphism with colorectal cancer risk and prognosis in Swedish and Chinese populations. Scand J Gastroenterol. 2007;42:345‐350. PubMed

Bermano G, Pagmantidis V, Holloway N, et al. Evidence that a polymorphism within the 3′ UTR of glutathione peroxidase 4 is functional and is associated with susceptibility to colorectal cancer. Genes Nutrition. 2007;2:225‐232. PubMed PMC

Méplan C, Hesketh J. Genetic polymorphisms in selenoprotein P gene affect colorectal, prostate and breast cancer risk. Proc Nutrition Soc. 2013;72.

Dimberg J, Skarstedt M, Löfgren S, Zar N, Matussek A. Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer. Biomed Rep. 2014;2:340‐343. PubMed PMC

Fan Y, Zhang X, Yang Z‐H, et al. The polymorphisms of osteopontin gene and plasma osteopontin protein levels with susceptibility to colorectal carcinoma. DNA Cell Biol. 2013;32:594‐600. PubMed

Kamal A, Darwish RK, Saad S, et al. Association of osteopontin gene polymorphisms with colorectal cancer. Cancer Invest. 2017;35:71‐77. PubMed

Xia X, Xu E, Quan S, Huang Q, Lai M. No association between the polymorphisms in CDX2 coding regions and colorectal cancer in Chinese. Mol Cell Biochem. 2009;331:27. PubMed

Xicola RM, Bontu S, Doyle BJ, et al. Association of a let‐7 miRNA binding region of TGFBR1 with hereditary mismatch repair proficient colorectal cancer (MSS HNPCC). Carcinogenesis. 2016;37:751‐758. PubMed PMC

Gong Z, Bostick RM, Xie D, et al. Genetic polymorphisms in the cyclooxygenase‐1 and cyclooxygenase‐2 genes and risk of colorectal adenoma. Int J Colorectal Dis. 2009;24:647‐654. PubMed PMC

Li Y, Jing F, Ding Y, He Q, Zhong Y, Fan C. Long noncoding RNA CCAT1 polymorphisms are associated with the risk of colorectal cancer. Cancer Genet. 2018;222:13‐19. PubMed

Iglesias D, Nejda N, Azcoita MM, Schwartz S, González‐Aguilera JJ. Effect of COX2‐765G> C and c. 3618A> G polymorphisms on the risk and survival of sporadic colorectal cancer. Cancer Causes Control. 2009;20:1421‐1429. PubMed

Slattery ML, Curtin K, Poole EM, et al. Genetic variation in C‐reactive protein in relation to colon and rectal cancer risk and survival. Int J Cancer. 2011;128:2726‐2734. PubMed PMC

Rasool S, Kadla SA, Rasool V, et al. Role of the VDR Bsm I and Apa I polymorphisms in the risk of colorectal cancer in Kashmir. Oncol Res Treatment. 2014;37:345‐349. PubMed

Cheng T‐YD, Makar KW, Neuhouser ML, et al. Interaction between genetic variants in one‐carbon metabolism and folate biomarkers on colorectal cancer risk: The Women's Health Initiative observational cohort [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5–9; San Diego, CA. Philadelphia (PA): AACR; Caner Research. 2014;74(19 Suppl): Abstract nr 2197.

Zhang H, Liao L‐H, Liu S‐M, et al. Microsomal glutathione S‐transferase gene polymorphisms and colorectal cancer risk in a Han Chinese population. Int J Colorectal Dis. 2007;22:1185‐1194. PubMed

Jeon YJ, Kim JW, Park HM, et al. Interplay between 3′‐UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans. BMC Cancer. 2014;14:881. PubMed PMC

Cho SH, Ko JJ, Kim JO, et al. 3’‐Utr polymorphisms in the mirna machinery genes drosha, dicer1, ran, and xpo5 are associated with colorectal cancer risk in a Korean population. PLoS ONE. 2015;10:e0131125. PubMed PMC

Tomsic J, Guda K, Liyanarachchi S, et al. Allele‐specific expression of TGFBR1 in colon cancer patients. Carcinogenesis. 2010;31:1800‐1804. PubMed PMC

Lin M, Zhang L, Hildebrandt MA, Huang M, Wu X, Ye Y. Common, germline genetic variations in the novel tumor suppressor BAP1 and risk of developing different types of cancer. Oncotarget. 2017;8:74936. PubMed PMC

Jeon YJ, Kim JW, Park HM, et al. Genetic variants in 3′‐UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans. Sci Rep. 2015;5:11006. PubMed PMC

Yang M, Xiao X, Xing X, Li X, Xia T, Long H. KRAS and VEGF gene 3'‐UTR single nucleotide polymorphisms predicted susceptibility in colorectal cancer. PLoS ONE. 2017;12:e0174140. PubMed PMC

Budhathoki S, Yamaji T, Iwasaki M, et al. Vitamin D receptor gene polymorphism and the risk of colorectal cancer: a nested case‐control study. PLoS ONE. 2016;11:e0164648. PubMed PMC

Poole EM, Hsu L, Xiao L, et al. Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2010;19:547‐557. PubMed PMC

Schafmayer C, Buch S, Egberts JH, et al. Genetic investigation of DNA‐repair pathway genes PMS2, MLH1, MSH2, MSH6, MUTYH, OGG1 and MTH1 in sporadic colon cancer. Int J Cancer. 2007;121:555‐558. PubMed

Cheng T‐Y, Makar KW, Neuhouser ML, et al. Folate‐mediated one‐carbon metabolism genes and interactions with nutritional factors on colorectal cancer risk: Women's Health Initiative Observational Study. Cancer. 2015;121:3684‐3691. PubMed PMC

Landi D, Moreno V, Guino E, et al. Polymorphisms affecting micro‐RNA regulation and associated with the risk of dietary‐related cancers: a review from the literature and new evidence for a functional role of rs17281995 (CD86) and rs1051690 (INSR), previously associated with colorectal cancer. Mutat Res. 2011;717:109‐115. PubMed

Ryan BM, Robles AI, Harris CC. KRAS‐LCS6 genotype as a prognostic marker in early‐stage CRC–letter. Clin Cancer Res. 2012;18:3487‐3488. PubMed PMC

Takeshige N, Yin G, Ohnaka K, et al. Associations between vitamin D receptor (VDR) gene polymorphisms and colorectal cancer risk and effect modifications of dietary calcium and vitamin D in a Japanese population. Asian Pac J Cancer Prev. 2015;16:2019‐2026. PubMed

Park K, Woo M, Nam J, Kim JC. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk. Cancer Lett. 2006;237:199‐206. PubMed

Hughes DJ, Hlavatá I, Soucek P, et al. Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic. J Gastrointest Cancer. 2011;42:149‐154. PubMed

Bentley RW, Keown DA, Gearry RB, et al. Vitamin D receptor polymorphisms in colorectal cancer in New Zealand: an association study. NZ Med J. 2012;125:47‐51. PubMed

Gromowski T, Kąklewski K, Marciniak W, et al. Vitamin D concentration and frequent variants of VDR gene as a markers of detection probability of breast, lung, prostate and colorectal cancers. (PhD theses). International Conference "Clinical Genetics of Cancer"; 2016.

Flügge J, Krusekopf S, Goldammer M, et al. Vitamin D receptor haplotypes protect against development of colorectal cancer. Eur J Clin Pharmacol. 2007;63:997‐1005. PubMed

Mahmoudi T, Mohebbi SR, Pourhoseingholi MA, Fatemi SR, Zali MR. Vitamin D receptor gene ApaI polymorphism is associated with susceptibility to colorectal cancer. Dig Dis Sci. 2010;55:2008‐2013. PubMed

Moossavi M, Parsamanesh N, Mohammadoo‐Khorasani M, et al. Positive correlation between vitamin D receptor gene FokI polymorphism and colorectal cancer susceptibility in South‐Khorasan of Iran. J Cell Biochem. 2018;119:8190‐8194. PubMed

Safaei A, Rostami F, Karimi AM, Kh AE, Khorshidi F. Association of vitamin D receptor polymorphism (VDR rs 2238136) with colorectal cancer. J Kerman Univ Med Sci. 2012;19:1‐8.

Atoum MF, Tchoporyan MN. Association between circulating vitamin D, the Taq1 vitamin D receptor gene polymorphism and colorectal cancer risk among Jordanians. Asian Pac J Cancer Prev. 2014;15:7337‐7341. PubMed

Chae YS, Kim JG, Sohn SK, et al. Association of vascular endothelial growth factor gene polymorphisms with susceptibility and clinicopathologic characteristics of colorectal cancer. J Korean Med Sci. 2008;23:421‐427. PubMed PMC

Gündüz M, Cacına C, Toptaş B, Yaylım‐Eraltan İ, Tekand Y, İsbir T. Association of vitamin D receptor gene polymorphisms with colon cancer. Genetic Testing Mol Biomarkers. 2012;16:1058‐1061. PubMed

Yaylım‐Eraltan İ, Arzu Ergen H, Arıkan S, et al. Investigation of the VDR gene polymorphisms association with susceptibility to colorectal cancer. Cell Biochem Funct. 2007;25:731‐737. PubMed

Dilmec F, Özgönül A, Akkafa F, Uzunkoy A, van Kuilenburg AB. Determination of ApaI and TaqI Polymorphisms of VDR gene in a group of Turkish patients with colorectal cancer. Int J Hematol Oncol. 2009;28:18‐22.

Kupfer SS, Anderson JR, Ludvik AE, et al. Genetic associations in the vitamin D receptor and colorectal cancer in African Americans and Caucasians. PLoS ONE. 2011;6:e26123. PubMed PMC

Slattery ML, Yakumo K, Hoffman M, Neuhausen S. Variants of the VDR gene and risk of colon cancer (United States). Cancer Causes Control. 2001;12:359‐364. PubMed

Ochs‐Balcom HM, Cicek MS, Thompson CL, et al. Association of vitamin D receptor gene variants, adiposity and colon cancer. Carcinogenesis. 2008;29:1788‐1793. PubMed PMC

Yamaji T, Iwasaki M, Sasazuki S, Sakamoto H, Yoshida T, Tsugane S. Association between plasma 25‐hydroxyvitamin D and colorectal adenoma according to dietary calcium intake and vitamin D receptor polymorphism. Am J Epidemiol. 2011;175:236‐244. PubMed

Peters U, Hayes RB, Chatterjee N, et al. Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Prev Biomarkers. 2004;13:546‐552. PubMed

Hofmann G, Langsenlehner U, Renner W, et al. Common single nucleotide polymorphisms in the vascular endothelial growth factor gene and colorectal cancer risk. J Cancer Res Clin Oncol. 2008;134:591‐595. PubMed

Wu G‐Y, Hasenberg T, Magdeburg R, Bönninghoff R, Sturm JW, Keese M. Association between EGF, TGF‐β1, VEGF gene polymorphism and colorectal cancer. World J Surg. 2009;33:124‐129. PubMed

Bayhan Z, Simşek T, Ergül E, Utkan NZ, Canturk NZ, Cekmen M. Serum cytokine levels in patients with colorectal cancers according to tumor stages and VEGF gene polymorphism. Hepatogastroenterology. 2014;61:1889‐1894. PubMed

Jannuzzi AT, Özhan G, Yanar HT, Alpertunga B. VEGF gene polymorphisms and susceptibility to colorectal cancer. Genetic Test Mol Biomarkers. 2015;19:133‐137. PubMed

Su C, Li D, Li N, et al. Studying the mechanism of PLAGL2 overexpression and its carcinogenic characteristics based on 3'‐untranslated region in colorectal cancer. Int J Oncol. 2018;52:1479‐1490. PubMed PMC

Jang MJ, Jeon YJ, Kim JW, et al. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans. Mol Carcinog. 2013;52:60‐69. PubMed

Lau T, Roslani A, Lian L, et al. Association between EGF and VEGF functional polymorphisms and sporadic colorectal cancer in the Malaysian population. Genet Mol Res. 2014;13:5555‐5561. PubMed

Credidio L, Lima C, Leal R, et al. C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma. BMC Res Notes. 2014;7:768. PubMed PMC

Wu X, Li D, Liu Z, et al. Vascular endothelial growth factor 1498C/T, 936C/T polymorphisms associated with increased risk of colorectal adenoma: a Chinese case–control study. Mol Biol Rep. 2011;38:1949‐1955. PubMed

Hou R, Liu Y, Feng Y, et al. Association of single nucleotide polymorphisms of ERCC1 and XPF with colorectal cancer risk and interaction with tobacco use. Gene. 2014;548:1‐5. PubMed

Moreno V, Gemignani F, Landi S, et al. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res. 2006;12:2101‐2108. PubMed

Ni M, Zhang W‐Z, Qiu J‐R, et al. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Sci Rep. 2014;4:4112. PubMed PMC

Yueh T‐C, Chou A‐K, Gong C‐L, et al. The contribution of excision repair cross‐complementing group 1 genotypes to colorectal cancer susceptibility in Taiwan. Anticancer Res. 2017;37:2307‐2313. PubMed

Makar KW, Poole EM, Resler AJ, et al. COX‐1 (PTGS1) and COX‐2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control. 2013;24:2059‐2075. PubMed PMC

Siezen CL, Bueno‐de‐Mesquita HB, Peeters PH, Kram NR, van Doeselaar M, van Kranen HJ. Polymorphisms in the genes involved in the arachidonic acid‐pathway, fish consumption and the risk of colorectal cancer. Int J Cancer. 2006;119:297‐303. PubMed

Vogel LK, Sæbø M, Høyer H, et al. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis. PLoS ONE. 2014;9:e105254. PubMed PMC

Cox D, Pontes C, Guinó E, et al. Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer. Br J Cancer. 2004;91:339. PubMed PMC

Andersen V, Holst R, Kopp TI, Tjønneland A, Vogel U. Interactions between diet, lifestyle and IL10, IL1B, and PTGS2/COX‐2 gene polymorphisms in relation to risk of colorectal cancer in a prospective Danish case‐cohort study. PLoS ONE. 2013;8:e78366. PubMed PMC

Thompson CL, Plummer SJ, Merkulova A, et al. No association between cyclooxygenase‐2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk. World J Gastroenterol. 2009;15:2240. PubMed PMC

Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N. Inflammation‐related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Prev Biomarkers. 2006;15:1126‐1131. PubMed

Pereira C, Queirós S, Galaghar A, et al. Influence of genetic polymorphisms in prostaglandin E2 pathway (COX‐2/HPGD/SLCO2A1/ABCC4) on the risk for colorectal adenoma development and recurrence after polypectomy. Clin Transl Gastroenterol. 2016;7:e191. PubMed PMC

Siezen CL, Tijhuis MJ, Kram NR, et al. Protective effect of nonsteroidal anti‐inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator‐activated receptor δ. Pharmacogenet Genomics. 2006;16:43‐50. PubMed

Ali I, Luke B, Dean M, Greenwald P. Allellic variants in regulatory regions of cyclooxygenase‐2: association with advanced colorectal adenoma. Br J Cancer. 2005;93:953. PubMed PMC

Ashktorab H, Tsang S, Luke B, et al. Protective effect of Cox‐2 allelic variants on risk of colorectal adenoma development in African Americans. Anticancer Res. 2008;28:3119‐3123. PubMed PMC

Ueda N, Maehara Y, Tajima O, Tabata S, Wakabayashi K, Kono S. Genetic polymorphisms of cyclooxygenase‐2 and colorectal adenoma risk: The Self Defense Forces Health Study. Cancer Sci. 2008;99:576‐581. PubMed PMC

Ramzi NH, Chahil JK, Lye SH, et al. Role of genetic & environment risk factors in the aetiology of colorectal cancer in Malaysia. Indian J Med Res. 2014;139:873. PubMed PMC

Razmkhah M, Ghaderi A. SDF‐1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers. Indian J Gastroenterol. 2013;32:28‐31. PubMed

Amara S, Chaar I, Khiari M, et al. Relationship between SDF‐1G801A polymorphism and its expression in Tunisian patients with colorectal cancer. J Immunoassay Immunochem. 2015;36:182‐194. PubMed

Larriba MJ, Bonilla F, Muñoz A. The transcription factors Snail1 and Snail2 repress vitamin D receptor during colon cancer progression. J Steroid Biochem Mol Biol. 2010;121:106‐109. PubMed

Touvier M, Chan DS, Lau R, et al. Meta‐analyses of vitamin D intake, 25‐hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Prev Biomarkers. 2011;20:1003‐1016. PubMed

Bai Y‐H, Lu H, Hong D, Lin C‐C, Yu Z, Chen B‐C. Vitamin D receptor gene polymorphisms and colorectal cancer risk: a systematic meta‐analysis. World J Gastroenterol. 2012;18:1672. PubMed PMC

Xu Y, He B, Pan Y, et al. Systematic review and meta‐analysis on vitamin D receptor polymorphisms and cancer risk. Tumor Biol. 2014;35:4153‐4169. PubMed

Sheng S, Chen Y, Shen Z. Correlation between polymorphism of vitamin D receptor TaqI and susceptibility to colorectal cancer: a meta‐analysis. Medicine. 2017;96:e7242. PubMed PMC

Pan Z, Chen M, Hu X, et al. Associations between VDR gene polymorphisms and colorectal cancer susceptibility: an updated meta‐analysis based on 39 case‐control studies. Oncotarget. 2018;9:13068. PubMed PMC

Serrano D, Gnagnarella P, Raimondi S, Gandini S. Meta‐analysis on vitamin D receptor and cancer risk: focus on the role of TaqI, ApaI, and Cdx2 polymorphisms. Eur J Cancer Prev. 2016;25:85. PubMed PMC

Bienertová‐Vašků J, Drábová K, Zlámal F, et al. Pre‐treatment VD levels and VDR receptors as potential predictors of occurrence and overall survival in paediatric patients with solid tumours—A single institution pilot study. Tumor Biol. 2016;37:9209‐9219. PubMed

Buroker NE, Ning X‐H, Zhou Z‐N, et al. SNPs, linkage disequilibrium, and chronic mountain sickness in Tibetan Chinese. Hypoxia. 2017;5:67. PubMed PMC

Sun W. Angiogenesis in metastatic colorectal cancer and the benefits of targeted therapy. J Hematol Oncol. 2012;5:63. PubMed PMC

Zhou L, Luan H, Dong X, Jin G, Man D, Shang H. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta‐analysis. Genet Mol Res. 2011;10:3674‐3688. PubMed

Chen J, Sun N, Hu G, et al. Association of ERCC1 polymorphisms with the risk of colorectal cancer: a meta‐analysis. Crit Rev Eukaryot Gene Expr. 2017;27(3):267–275. PubMed

Sæbø M, Skjelbred CF, Nexø BA, et al. Increased mRNA expression levels of ERCC1, OGG1 and RAI in colorectal adenomas and carcinomas. BMC Cancer. 2006;6:208. PubMed PMC

Xu K, Dai H, Wang S, Zhang J, Liu T. The cXcl12 rs1801157 polymorphism and risk of colorectal cancer: a meta‐analysis. OncoTargets Ther. 2018;11:2445. PubMed PMC

Schulz M, Karpova D, Spohn G, et al. Variant rs1801157 in the 3’UTR of SDF‐1ss does not explain variability of healthy‐donor G‐CSF responsiveness. PLoS ONE. 2015;10:e0121859. PubMed PMC

Teicher BA, Fricker SP. CXCL12 (SDF‐1)/CXCR4 pathway in cancer. Clin Cancer Res. 2010;16:2927‐2931. PubMed

Du X‐Y, Hu Y‐Y, Xie C, et al. Significant association between Let‐7‐KRAS rs712 G> T polymorphism and cancer risk in the Chinese population: a meta‐analysis. Oncotarget. 2017;8:13863. PubMed PMC

Ying H‐Q, Wang F, He B‐S, et al. The involvement of Kras gene 3′‐UTR polymorphisms in risk of cancer and influence on patient response to anti‐EGFR therapy in metastatic colorectal cancer: a meta‐analysis. OncoTargets Ther. 2014;7:1487. PubMed PMC

Zhao W‐H, Qu X‐F, Xing Z‐G, Zhao L‐Q, Qin L, Lv C. Association of rs712 polymorphism in Kras gene 3’‐luntranslated region and cancer risk: a meta‐analysis. J BUON. 2015;20:309‐316. PubMed

Oczko‐Wojciechowska M, Pfeifer A, Rusinek D, et al. The prevalence of somatic RAS mutations in medullary thyroid cancer—a Polish population study. Endokrynologia Polska. 2015;66:121‐125. PubMed

Smith G, Bounds R, Wolf H, Steele R, Carey F, Wolf C. Activating K‐Ras mutations outwith ‘hotspot'codons in sporadic colorectal tumours–implications for personalised cancer medicine. Br J Cancer. 2010;102:693. PubMed PMC

Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, Dubois RN. Up‐regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994;107:1183‐1188. PubMed

Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860. PubMed PMC

Regulation of KRAS protein expression by miR-544a and KRAS-LCS6 polymorphism in wild-type KRAS sporadic colon adenocarcinoma